Endace 160 Tablet (Megestrol Acetate 160 mg) – 10 Tablets

About this Medicine

Endace 160 Tablet, featuring Megestrol Acetate 160 mg, is a vital prescription medication categorized under oncology, playing a dual role in patient care. Primarily, it is prescribed for individuals battling certain advanced cancers, specifically advanced breast cancer and advanced endometrial cancer. As a synthetic progestin, Megestrol Acetate works by exerting hormone-modulating effects within the body. In hormone-sensitive cancers like certain breast cancers, it may help to slow the growth of cancer cells by interfering with hormone pathways. For endometrial cancer, its progestational activity helps to counteract estrogenic effects, which can contribute to disease progression. Beyond its direct oncological applications, Endace 160 is also significantly valued for its ability to address a challenging aspect of many chronic illnesses, particularly cancer: profound appetite loss and unintentional weight loss, often referred to as cachexia. This condition can severely impact a patient's quality of life, energy levels, and overall response to treatment. By stimulating appetite and promoting weight gain, Endace 160 helps improve nutritional status, which can be crucial for maintaining strength and resilience during demanding medical treatments. It is imperative that Endace 160 Tablet is used strictly under the guidance of a healthcare professional. Your doctor will determine the appropriate dosage and treatment duration based on your specific medical condition, overall health, and response to therapy. Regular monitoring will be necessary to assess its effectiveness and manage any potential side effects. Patients should not self-medicate or adjust their dosage without consulting their physician. Always discuss your complete medical history and any other medications you are taking to ensure safe and effective treatment with Endace 160. This medication represents a targeted approach to managing complex aspects of cancer and its related symptoms, aiming to improve patient outcomes and well-being.